Lisa Paborsky
Director de Operaciones en Ilios Therapeutics, Inc. .
Origen de la red de primer grado Lisa Paborsky.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Mitobridge, Inc.
Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA.
4
| Subsidiary | Biotechnology | 4 |
Ilios Therapeutics, Inc.
Ilios Therapeutics, Inc. Packaged SoftwareTechnology Services Ilios Therapeutics, Inc. develops a chemistry platform to generate therapeutics for neurodegenerative diseases. The American company was founded by Luca Giani and he has been the CEO since incorporation.
1
| Holding Company | Packaged Software | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Lisa Paborsky a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
VERASTEM, INC. | Biotechnology | Founder Director/Board Member | |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
MPM Oncology Impact Management LP
MPM Oncology Impact Management LP Investment ManagersFinance MPM Oncology Impact Management LP (OIM) is a hedge fund management firm headquartered in Cambridge, Massachusetts. The firm is a subsidiary of MPM Oncology Impact Management GP LLC, which is owned by MPM Capital, Inc. OIM provides investment supervisory services to investment vehicles. | Investment Managers | Corporate Officer/Principal | |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Florida Healthcare Analytics, Inc.
Florida Healthcare Analytics, Inc. Packaged SoftwareTechnology Services Part of Clinical Ink, Inc., Florida Healthcare Analytics, Inc. provides mobile applications for clinical trial patient engagement and electronic patient reported outcomes. The company is based in Boston, MA. The company was founded by Jeremy Sohn. Florida Healthcare Analytics was acquired by Clinical Ink, Inc. on March 29, 2015. | Packaged Software | Director/Board Member | |
Clinical Ink, Inc.
Clinical Ink, Inc. Internet Software/ServicesTechnology Services Clinical Ink, Inc. provides electronic source solutions for clinical research sites. Its solutions include data management, monitoring, clinical sites and patient centric. The company was founded by Douglas E. Pierce Jr. and Tommy Littlejohn on July 19, 2006 and is headquartered in Winston-Salem, NC. | Internet Software/Services | Director/Board Member | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ALLOVIR, INC. | Biotechnology | Director/Board Member | |
TriNetX, LLC
TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
OSS Healthcare, Inc. | Director/Board Member | ||
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MPM BioVentures V LLC | Corporate Officer/Principal | ||
MPM BioVentures V GP LLC | Corporate Officer/Principal | ||
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Kourion Therapeutics
Kourion Therapeutics Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., Kourion Therapeutics is a German company that researches and develops initiatives for stem cell technology, used for the regeneration of cardiac, neuronal, hepatic, and bone tissues. The company is based in Dusseldorf, Germany. Kourion Therapeutics was acquired by ViaCell, Inc., part of Revvity, Inc. from November 16, 2007 on November 12, 2003. | Miscellaneous Commercial Services | Director/Board Member | |
ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
McGill University | College/University | Masters Business Admin | |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investment Managers | Private Equity Investor | |
Nanna Therapeutics Ltd.
Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | President | |
ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ONO PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Private Equity Investor | |
Ono Pharma USA, Inc.
Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | Internet Software/Services | Private Equity Investor | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Private Equity Investor | |
Ono Venture Investment, Inc.
Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Kyoto University | College/University | Graduate Degree | |
University of Tsukuba | College/University | Doctorate Degree | |
Renagade Therapeutics, Inc.
Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder | |
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Bioimpact Capital LLC
Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
UBS Oncology Impact Fund
UBS Oncology Impact Fund Investment ManagersFinance UBS Oncology Impact Fund is an American private company located in Cambridge, MA, with a presence in the Cayman Islands, that functions as a family of funds. | Investment Managers | Director/Board Member | |
MPM Sunstates GP Managing Member LLC | Corporate Officer/Principal | ||
Cullinan Pearl Corp.
Cullinan Pearl Corp. BiotechnologyHealth Technology Part of Otsuka Holdings Co., Ltd., Cullinan Pearl Corp. is a company that develops an orally available tyrosine kinase inhibitor. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. Cullinan Pearl was acquired by Taiho Pharmaceutical Co., Ltd. from Cullinan Oncology, Inc. on June 23, 2022 for $405 million. | Biotechnology | Director/Board Member | |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chairman | |
Dragonfly Sciences, Inc.
Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 41 |
Japón | 5 |
Alemania | 3 |
Canadá | 3 |
Reino Unido | 3 |
Sectorial
Health Technology | 22 |
Finance | 9 |
Commercial Services | 7 |
Consumer Services | 5 |
Health Services | 4 |
Operativa
Director/Board Member | 60 |
Corporate Officer/Principal | 19 |
Founder | 17 |
Independent Dir/Board Member | 11 |
Chairman | 10 |
Las relaciones más conectadas
Insiders | |
---|---|
Ansbert Gadicke | 56 |
Richard H. Aldrich | 31 |
Shunichiro Matsumoto | 10 |
David Barrett | 5 |
Luca Giani | 1 |
- Bolsa de valores
- Insiders
- Lisa Paborsky
- Conexiones Empresas